Patents by Inventor Judith Kelleher-Andersson

Judith Kelleher-Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of fused nicotinamides to promote neurogenesis
    Patent number: 7858628
    Abstract: The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: December 28, 2010
    Assignee: Neuralstem, Inc.
    Inventors: Judith Kelleher-Andersson, Karl K. Johe
  • METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS AND INHIBITING NEURONAL DEGENERATION USING ISOTHIAZOLOPYRIMIDINONES
    Publication number: 20100298318
    Abstract: The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, traumatic nerve injury, and depression. This invention is useful for resear products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.
    Type: Application
    Filed: June 20, 2008
    Publication date: November 25, 2010
    Applicant: NEURONASCENT, INC.
    Inventor: Judith Kelleher-Andersson
  • USE OF FUSED NICOTINAMIDES TO PROMOTE NEUROGENESIS
    Publication number: 20100034784
    Abstract: The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.
    Type: Application
    Filed: July 9, 2009
    Publication date: February 11, 2010
    Applicant: NEURALSTEM, INC.
    Inventors: Judith KELLEHER-ANDERSSON, Karl K. JOHE
  • Isolation and Differentiation of Adult Hippocampal Arctic Squirrel Neural Stem Cells
    Publication number: 20090305403
    Abstract: Neuronal stem cell lines derived from the Arctic Ground Squirrel, methods related to culturing and maintaining a neuronal stem cell line derived from the Arctic Ground Squirrel and a culture media required to maintain and differentiate a neuronal stem cell line derived from the Arctic Ground Squirrel is disclosed. Antibodies specific for antigens expressed on a neuronal stem cell line derived from the Arctic Ground Squirrel, and products and methods related to the use of neuronal stem cell lines derived from the Arctic Ground Squirrel are also included.
    Type: Application
    Filed: August 31, 2007
    Publication date: December 10, 2009
    Applicant: Neuronascent, Inc.
    Inventor: Judith Kelleher-Andersson
  • Use of fuse nicotinamides to promote neurogenesis
    Patent number: 7560553
    Abstract: The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: July 14, 2009
    Assignee: Neuralstem, Inc.
    Inventors: Judith Kelleher-Andersson, Karl K. Johe
  • Methods and Compositons for Stimulating Neurogenesis and Inhibiting Neuronal Degeneration
    Publication number: 20080234253
    Abstract: The present invention provides methods and compositions comprising compounds useful for stimulating neurogenesis. The methods and compositions comprising compounds are also useful for inhibiting neuronal degeneration. Thus, the present invention can be used in the treatment of diseases and conditions characterized by neuronal loss and reduced neurogenesis including Alzheimer's disease, stroke, traumatic brain injury, and depression. This invention could also be used for research products including single agents or mixtures of agents to promote, proliferate, differentiate, or maintain neurons from stem or progenitor cells.
    Type: Application
    Filed: September 19, 2006
    Publication date: September 25, 2008
    Applicant: NEURONASCENT, INC.
    Inventor: Judith Kelleher-Andersson
  • METHOD FOR DISCOVERING NEUROGENIC AGENTS
    Publication number: 20080057530
    Abstract: A method for discovering neurogenic drugs is revealed. The method allows for systematic screening of test agents such as libraries of compounds. The method consists of exposing test agents to cultures of differentiating neural progenitor cells and measuring their effects on increasing the overall cell number and/or the number of neurons.
    Type: Application
    Filed: September 10, 2007
    Publication date: March 6, 2008
    Applicant: NEURALSTEM, INC.
    Inventors: Judith Kelleher-Andersson, Karl Johe
  • Method for discovering neurogenic agents
    Publication number: 20040185429
    Abstract: A method for discovering neurogenic drugs is revealed. The method allows for systematic screening of test agents such as libraries of compounds. The method consists of exposing test agents to cultures of differentiating neural progenitor cells and measuring their effects on increasing the overall cell number and/or the number of neurons.
    Type: Application
    Filed: December 5, 2003
    Publication date: September 23, 2004
    Inventors: Judith Kelleher-Andersson, Karl K. Johe